First clinical trial of MS remyelination therapy PTD802 cleared in... PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in multiple sclerosis.

This can't happen fast enough for me! #MSWarrior #MSActivist #MSRepair #Remyelination #MyelinRepair
multiplesclerosisnewstoday.com/news-posts/2...

Honored to have received the Harry Weaver Neuroscience Scholar Award from National Multiple Sclerosis Society! Thank you @mssociety for supporting our research @GUBiology @Georgetown. #MSRepair #MakeMyelinRegenerateAgain